NO310094B1 - Anvendelse av bioaktivt silikaglass og sammensetninger som inneholder bioaktivt silikaglass - Google Patents
Anvendelse av bioaktivt silikaglass og sammensetninger som inneholder bioaktivt silikaglass Download PDFInfo
- Publication number
- NO310094B1 NO310094B1 NO19971563A NO971563A NO310094B1 NO 310094 B1 NO310094 B1 NO 310094B1 NO 19971563 A NO19971563 A NO 19971563A NO 971563 A NO971563 A NO 971563A NO 310094 B1 NO310094 B1 NO 310094B1
- Authority
- NO
- Norway
- Prior art keywords
- composition
- dentin
- glass
- tooth
- silica
- Prior art date
Links
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 title claims abstract description 89
- 230000000975 bioactive effect Effects 0.000 title claims abstract description 21
- 239000000203 mixture Substances 0.000 title claims description 63
- 239000011521 glass Substances 0.000 claims abstract description 67
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 40
- 239000011575 calcium Substances 0.000 claims abstract description 23
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 22
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 18
- 230000007794 irritation Effects 0.000 claims abstract description 18
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims abstract description 18
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 13
- 239000010452 phosphate Substances 0.000 claims abstract description 12
- 239000007788 liquid Substances 0.000 claims abstract description 8
- 239000000725 suspension Substances 0.000 claims abstract description 6
- 210000004268 dentin Anatomy 0.000 claims description 95
- 239000013078 crystal Substances 0.000 claims description 23
- 239000000126 substance Substances 0.000 claims description 21
- 239000000243 solution Substances 0.000 claims description 19
- 239000000843 powder Substances 0.000 claims description 18
- 239000006072 paste Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 6
- 229910004298 SiO 2 Inorganic materials 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 229910052698 phosphorus Inorganic materials 0.000 claims description 5
- 239000000741 silica gel Substances 0.000 claims description 5
- 229910002027 silica gel Inorganic materials 0.000 claims description 5
- 229910008051 Si-OH Inorganic materials 0.000 claims description 4
- 229910006358 Si—OH Inorganic materials 0.000 claims description 4
- 229910052731 fluorine Inorganic materials 0.000 claims description 4
- -1 silica gel Chemical compound 0.000 claims description 4
- 238000005728 strengthening Methods 0.000 claims description 4
- 238000012546 transfer Methods 0.000 claims description 4
- 229920002101 Chitin Polymers 0.000 claims description 3
- 102000008946 Fibrinogen Human genes 0.000 claims description 3
- 108010049003 Fibrinogen Proteins 0.000 claims description 3
- KKCBUQHMOMHUOY-UHFFFAOYSA-N Na2O Inorganic materials [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 claims description 3
- 229910052782 aluminium Inorganic materials 0.000 claims description 3
- 239000011230 binding agent Substances 0.000 claims description 3
- 229910052796 boron Inorganic materials 0.000 claims description 3
- 229940012952 fibrinogen Drugs 0.000 claims description 3
- 230000003993 interaction Effects 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 229910052719 titanium Inorganic materials 0.000 claims description 3
- 239000000919 ceramic Substances 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 abstract description 30
- 239000000463 material Substances 0.000 abstract description 15
- 238000002360 preparation method Methods 0.000 abstract description 10
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 44
- 238000000034 method Methods 0.000 description 31
- 208000002193 Pain Diseases 0.000 description 22
- 230000033558 biomineral tissue development Effects 0.000 description 21
- 206010020751 Hypersensitivity Diseases 0.000 description 20
- 230000036407 pain Effects 0.000 description 20
- 210000003074 dental pulp Anatomy 0.000 description 17
- 210000001519 tissue Anatomy 0.000 description 15
- 230000008569 process Effects 0.000 description 14
- 230000000694 effects Effects 0.000 description 13
- 238000011049 filling Methods 0.000 description 12
- 150000002500 ions Chemical class 0.000 description 12
- 239000005313 bioactive glass Substances 0.000 description 11
- 239000012530 fluid Substances 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 9
- 210000002808 connective tissue Anatomy 0.000 description 9
- 238000002425 crystallisation Methods 0.000 description 9
- 230000008025 crystallization Effects 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 208000002925 dental caries Diseases 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 102000008186 Collagen Human genes 0.000 description 7
- 108010035532 Collagen Proteins 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 229920001436 collagen Polymers 0.000 description 7
- 210000004416 odontoblast Anatomy 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- 239000000606 toothpaste Substances 0.000 description 7
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 6
- 229910052586 apatite Inorganic materials 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 6
- 208000026935 allergic disease Diseases 0.000 description 5
- 210000004262 dental pulp cavity Anatomy 0.000 description 5
- 239000003178 glass ionomer cement Substances 0.000 description 5
- 230000035876 healing Effects 0.000 description 5
- 210000000214 mouth Anatomy 0.000 description 5
- 230000001681 protective effect Effects 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 4
- 239000000920 calcium hydroxide Substances 0.000 description 4
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 4
- 239000004568 cement Substances 0.000 description 4
- 210000003298 dental enamel Anatomy 0.000 description 4
- 230000009610 hypersensitivity Effects 0.000 description 4
- 230000003239 periodontal effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000012266 salt solution Substances 0.000 description 4
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000001680 brushing effect Effects 0.000 description 3
- 239000001506 calcium phosphate Substances 0.000 description 3
- 229910000389 calcium phosphate Inorganic materials 0.000 description 3
- 235000011010 calcium phosphates Nutrition 0.000 description 3
- 210000000981 epithelium Anatomy 0.000 description 3
- 210000002744 extracellular matrix Anatomy 0.000 description 3
- 210000004195 gingiva Anatomy 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000005342 ion exchange Methods 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 210000003739 neck Anatomy 0.000 description 3
- 210000001640 nerve ending Anatomy 0.000 description 3
- 230000000604 odontoblastic effect Effects 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 210000004499 secondary dentin Anatomy 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
- 239000002966 varnish Substances 0.000 description 3
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 239000004115 Sodium Silicate Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 208000005298 acute pain Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 description 2
- 229910001634 calcium fluoride Inorganic materials 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000002170 dentin sensitivity Diseases 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 150000002222 fluorine compounds Chemical class 0.000 description 2
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 239000002667 nucleating agent Substances 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 230000006911 nucleation Effects 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 2
- 229940085991 phosphate ion Drugs 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 235000019353 potassium silicate Nutrition 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229910001961 silver nitrate Inorganic materials 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229910052911 sodium silicate Inorganic materials 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000012090 tissue culture technique Methods 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 208000032841 Bulimia Diseases 0.000 description 1
- 206010006550 Bulimia nervosa Diseases 0.000 description 1
- 102000005701 Calcium-Binding Proteins Human genes 0.000 description 1
- 108010045403 Calcium-Binding Proteins Proteins 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
- 102000009890 Osteonectin Human genes 0.000 description 1
- 108010077077 Osteonectin Proteins 0.000 description 1
- 208000000114 Pain Threshold Diseases 0.000 description 1
- 208000005888 Periodontal Pocket Diseases 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 102000007982 Phosphoproteins Human genes 0.000 description 1
- 108010089430 Phosphoproteins Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 229910010413 TiO 2 Inorganic materials 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 238000011892 Von Kossa's method Methods 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000000316 bone substitute Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- NLCKLZIHJQEMCU-UHFFFAOYSA-N cyano prop-2-enoate Chemical class C=CC(=O)OC#N NLCKLZIHJQEMCU-UHFFFAOYSA-N 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000005115 demineralization Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000037123 dental health Effects 0.000 description 1
- 210000002531 dentinal fluid Anatomy 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- IRXRGVFLQOSHOH-UHFFFAOYSA-L dipotassium;oxalate Chemical compound [K+].[K+].[O-]C(=O)C([O-])=O IRXRGVFLQOSHOH-UHFFFAOYSA-L 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229940062993 ferrous oxalate Drugs 0.000 description 1
- ZIQLCYCKKROENE-UHFFFAOYSA-L fluoro-dioxido-oxo-$l^{5}-phosphane;tin(2+) Chemical compound [Sn+2].[O-]P([O-])(F)=O ZIQLCYCKKROENE-UHFFFAOYSA-L 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 231100000024 genotoxic Toxicity 0.000 description 1
- 230000001738 genotoxic effect Effects 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 210000000301 hemidesmosome Anatomy 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- OWZIYWAUNZMLRT-UHFFFAOYSA-L iron(2+);oxalate Chemical compound [Fe+2].[O-]C(=O)C([O-])=O OWZIYWAUNZMLRT-UHFFFAOYSA-L 0.000 description 1
- 210000001847 jaw Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000004576 lipid-binding Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000002050 maxilla Anatomy 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000037040 pain threshold Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 238000010587 phase diagram Methods 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 239000000276 potassium ferrocyanide Substances 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 238000010900 secondary nucleation Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000005368 silicate glass Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- BFDWBSRJQZPEEB-UHFFFAOYSA-L sodium fluorophosphate Chemical compound [Na+].[Na+].[O-]P([O-])(F)=O BFDWBSRJQZPEEB-UHFFFAOYSA-L 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- 229910001631 strontium chloride Inorganic materials 0.000 description 1
- AHBGXTDRMVNFER-UHFFFAOYSA-L strontium dichloride Chemical compound [Cl-].[Cl-].[Sr+2] AHBGXTDRMVNFER-UHFFFAOYSA-L 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000006557 surface reaction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- XOGGUFAVLNCTRS-UHFFFAOYSA-N tetrapotassium;iron(2+);hexacyanide Chemical compound [K+].[K+].[K+].[K+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] XOGGUFAVLNCTRS-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/802—Preparations for artificial teeth, for filling teeth or for capping teeth comprising ceramics
- A61K6/816—Preparations for artificial teeth, for filling teeth or for capping teeth comprising ceramics comprising titanium oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/15—Compositions characterised by their physical properties
- A61K6/17—Particle size
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/30—Compositions for temporarily or permanently fixing teeth or palates, e.g. primers for dental adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/50—Preparations specially adapted for dental root treatment
- A61K6/54—Filling; Sealing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/802—Preparations for artificial teeth, for filling teeth or for capping teeth comprising ceramics
- A61K6/807—Preparations for artificial teeth, for filling teeth or for capping teeth comprising ceramics comprising magnesium oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/831—Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
- A61K6/836—Glass
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Plastic & Reconstructive Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Ceramic Engineering (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Glass Compositions (AREA)
- Dental Preparations (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI944672A FI104881B (fi) | 1994-10-06 | 1994-10-06 | Uusien bioaktiivista piipitoista lasia sisältävien koostumusten valmistusmenetelmä |
PCT/FI1995/000539 WO1996010985A1 (fr) | 1994-10-06 | 1995-10-02 | Nouvelles utilisations de verres a la silice bioactive et nouvelles preparations les contenant |
Publications (3)
Publication Number | Publication Date |
---|---|
NO971563D0 NO971563D0 (no) | 1997-04-04 |
NO971563L NO971563L (no) | 1997-04-04 |
NO310094B1 true NO310094B1 (no) | 2001-05-21 |
Family
ID=8541520
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19971563A NO310094B1 (no) | 1994-10-06 | 1997-04-04 | Anvendelse av bioaktivt silikaglass og sammensetninger som inneholder bioaktivt silikaglass |
Country Status (16)
Country | Link |
---|---|
US (1) | US5891233A (fr) |
EP (1) | EP0804136B1 (fr) |
JP (1) | JP3524102B2 (fr) |
KR (1) | KR100381308B1 (fr) |
AT (1) | ATE238753T1 (fr) |
AU (1) | AU702580B2 (fr) |
CA (1) | CA2200218C (fr) |
CZ (1) | CZ292434B6 (fr) |
DE (1) | DE69530608T2 (fr) |
ES (1) | ES2198444T3 (fr) |
FI (1) | FI104881B (fr) |
HU (1) | HU222368B1 (fr) |
NO (1) | NO310094B1 (fr) |
PL (1) | PL319483A1 (fr) |
RU (1) | RU2152778C1 (fr) |
WO (1) | WO1996010985A1 (fr) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1103750C (zh) * | 1996-01-29 | 2003-03-26 | 巴尔的摩的马里兰大学 | 生物活性玻璃组合物以及使用生物活性玻璃的治疗方法 |
US5735942A (en) | 1996-02-07 | 1998-04-07 | Usbiomaterials Corporation | Compositions containing bioactive glass and their use in treating tooth hypersensitivity |
IN191261B (fr) * | 1997-09-18 | 2003-10-18 | Univ Maryland | |
US6190643B1 (en) | 1999-03-02 | 2001-02-20 | Patricia Stoor | Method for reducing the viability of detrimental oral microorganisms in an individual, and for prevention and/or treatment of diseases caused by such microorganisms; and whitening and/or cleaning of an individual's teeth |
GB9919283D0 (en) * | 1999-08-14 | 1999-10-20 | Algar Brian | A glass composition |
US7323160B2 (en) * | 1999-08-14 | 2008-01-29 | Teldent Ltd. | Method of treating a patient's teeth using fluoride releasing glass composition |
WO2001072145A1 (fr) | 2000-03-24 | 2001-10-04 | Ustherapeutics, Llc | Supplements nutritionnels prepares a partir de matieres bioactives |
RU2251405C2 (ru) | 2000-03-27 | 2005-05-10 | Шотт Глас | Композиции для косметических препаратов, средств личной гигиены, компонентов очищающего действия, пищевых добавок, способы их получения и применения |
US6375935B1 (en) | 2000-04-28 | 2002-04-23 | Brent R. Constantz | Calcium phosphate cements prepared from silicate solutions |
US7820191B2 (en) | 2000-04-28 | 2010-10-26 | Skeletal Kinetics, Llc | Calcium phosphate cements prepared from silicate solutions |
US6787584B2 (en) * | 2000-08-11 | 2004-09-07 | Pentron Corporation | Dental/medical compositions comprising degradable polymers and methods of manufacture thereof |
US20070059257A1 (en) * | 2000-08-18 | 2007-03-15 | Block Drug Company, Inc. | Dentinal composition for hypersensitive teeth |
DE10111449A1 (de) * | 2001-03-09 | 2002-09-26 | Schott Glas | Verwendung von bioaktivem Glas in Zahnfüllmaterial |
US7597900B2 (en) * | 2001-03-27 | 2009-10-06 | Schott Ag | Tissue abrasives |
ES2242851T3 (es) | 2001-03-30 | 2005-11-16 | King's College London | Utilizacion de vidrio bioactivo. |
US6416745B1 (en) | 2001-05-03 | 2002-07-09 | Block Drug Company, Inc. | Dental composition for treating hypersensitive teeth |
US7303817B2 (en) * | 2001-10-24 | 2007-12-04 | Weitao Jia | Dental filling material |
US7204874B2 (en) * | 2001-10-24 | 2007-04-17 | Pentron Clinical Technologies, Llc | Root canal filling material |
US7211136B2 (en) * | 2001-10-24 | 2007-05-01 | Pentron Clinical Technologies, Llc | Dental filling material |
US7750063B2 (en) | 2001-10-24 | 2010-07-06 | Pentron Clinical Technologies, Llc | Dental filling material |
US7204875B2 (en) * | 2001-10-24 | 2007-04-17 | Pentron Clinical Technologies, Llc | Dental filling material |
US20030167967A1 (en) * | 2002-03-01 | 2003-09-11 | Timo Narhi | Glass ionomers for enhancing mineralization of hard tissue |
US8128911B2 (en) | 2002-05-10 | 2012-03-06 | Colgate-Palmolive Company | Antibacterial dentifrice exhibiting enhanced antiplaque and breath freshening properties |
US8168208B1 (en) * | 2002-06-03 | 2012-05-01 | Ahmed El-Ghannam | Silica-calcium phosphate bioactive composite for improved synthetic graft resorbability and tissue regeneration |
JP2006518744A (ja) * | 2003-02-21 | 2006-08-17 | ローディア インコーポレイティド | 抗感受性、抗カリエス、抗しみ、抗歯垢、ウルトラマイルド口腔衛生物質 |
FI20030780A0 (fi) * | 2003-05-23 | 2003-05-23 | Bioxid Oy | Prepreg ja sen käyttö |
US20040250730A1 (en) * | 2003-06-12 | 2004-12-16 | David Delaney | Calcium phosphate cements prepared from silicate-phosphate solutions |
US7306786B2 (en) * | 2003-07-28 | 2007-12-11 | Skeletal Kinetics, Llc | Calcium phosphate cements comprising a water-soluble contrast agent |
EP1776083A4 (fr) * | 2004-07-02 | 2010-06-02 | Discus Dental Llc | Compositions dentaires soulageant la sensibilite |
EP2260828B1 (fr) | 2004-11-16 | 2015-08-05 | 3M Innovative Properties Co. | Charges dentaires, procédés, compositions incluant un caseinate |
US8957126B2 (en) | 2004-11-16 | 2015-02-17 | 3M Innovative Properties Company | Dental compositions with calcium phosphorus releasing glass |
JP2008520568A (ja) | 2004-11-16 | 2008-06-19 | スリーエム イノベイティブ プロパティズ カンパニー | リン含有表面処理を含む歯科用充填剤、ならびにその組成物および方法 |
CA2587275A1 (fr) * | 2004-11-16 | 2006-05-26 | 3M Innovative Properties Company | Charges dentaires et compositions incluant des sels de phosphate |
US20070258916A1 (en) * | 2006-04-14 | 2007-11-08 | Oregon Health & Science University | Oral compositions for treating tooth hypersensitivity |
GB0616716D0 (en) * | 2006-08-23 | 2006-10-04 | Novathera Ltd | Composite material |
WO2009076491A2 (fr) * | 2007-12-13 | 2009-06-18 | 3M Innovative Properties Company | Compositions et procédés de reminéralisation |
GB0801836D0 (en) * | 2008-01-31 | 2008-03-05 | Glaxo Group Ltd | Novel composition |
US20090197221A1 (en) * | 2008-02-04 | 2009-08-06 | Marshall Jr Grayson W | Dental bonding compositions and methods useful in inhibition of microleakage in resin-bonded dentin |
RU2460512C2 (ru) * | 2008-04-24 | 2012-09-10 | Габа Интернациональ Холдинг Аг | Композиция для ухода за полостью рта, включающая в себя растворенное олово и фторид |
US8221723B2 (en) | 2008-11-25 | 2012-07-17 | The Procter & Gamble Company | Oral care compositions with abrasive combinations |
US8551457B2 (en) | 2008-11-25 | 2013-10-08 | The Procter & Gamble Company | Oral care compositions comprising spherical fused silica |
WO2010068359A1 (fr) * | 2008-12-11 | 2010-06-17 | 3M Innovative Properties Company | Particules de phosphate de calcium traitées en surface pour soins buccaux et compositions dentaires |
FI20095084A0 (fi) | 2009-01-30 | 2009-01-30 | Pekka Vallittu | Komposiitti ja sen käyttö |
TWI469795B (zh) | 2009-04-01 | 2015-01-21 | Colgate Palmolive Co | 防止過敏和促進再礦化之雙作用牙劑組成物 |
TWI391148B (zh) | 2009-04-01 | 2013-04-01 | Colgate Palmolive Co | 含有生物可接受性及生物活性之玻璃的非水性牙膏組成物及其使用與製造之方法 |
US8603442B2 (en) | 2009-08-03 | 2013-12-10 | Mcneil-Ppc, Inc. | Tooth sensitivity treatment compositions |
US8632754B2 (en) | 2009-08-03 | 2014-01-21 | Mcneil-Ppc, Inc. | Tooth sensitivity treatment compositions |
US9060947B2 (en) | 2009-08-03 | 2015-06-23 | Mcneil-Ppc, Inc. | Tooth sensitivity treatment compositions |
US8715625B1 (en) | 2010-05-10 | 2014-05-06 | The Clorox Company | Natural oral care compositions |
US9511170B2 (en) | 2010-06-02 | 2016-12-06 | Cap Biomaterials, Llc | Glassy calcium phosphate particulates, coatings and related bone graft materials |
US8722080B2 (en) | 2011-03-11 | 2014-05-13 | Gary D. Hack | Treatment and prevention of dental pathology in humans and non-human animals |
GB201113754D0 (en) | 2011-08-09 | 2011-09-21 | Glaxo Group Ltd | Composition |
BR112014004760B8 (pt) | 2011-09-08 | 2019-01-02 | Unilever Nv | composição de dentifrício, método de remineralização e/ou branqueamento de dentes |
CN104334150B (zh) | 2012-04-05 | 2017-09-12 | 荷兰联合利华有限公司 | 非水口腔护理组合物 |
BR112015006955B1 (pt) | 2012-10-12 | 2019-06-25 | Unilever N.V. | Composição para a higiene bucal, método para aprimorar a higiene bucal e processos para a fabricação da composição para a higiene bucal |
US20140127145A1 (en) | 2012-11-05 | 2014-05-08 | The Procter & Gamble Company | Heat Treated Precipitated Silica |
US10111814B2 (en) * | 2013-04-19 | 2018-10-30 | National Taipei University Of Technology | Desensitizing toothpaste |
US9168114B2 (en) | 2013-10-17 | 2015-10-27 | B & D Dental Corp. | Method of making a dental prosthesis |
US20190365615A1 (en) | 2016-06-20 | 2019-12-05 | Helicon Medical, S.L. | Composition of materials for tooth remineralisation |
EP3479813A4 (fr) | 2016-06-30 | 2020-01-22 | GC Corporation | Matériel de traitement dentaire. |
GB201621685D0 (en) | 2016-12-20 | 2017-02-01 | Glaxosmithkline Consumer Healthcare (Uk) Ip Ltd | Novel composition |
EP3668604B1 (fr) | 2017-08-18 | 2021-10-13 | Unilever Global IP Limited | Composition de soins bucco-dentaires |
EP3668477A1 (fr) | 2017-08-18 | 2020-06-24 | Unilever N.V. | Composition pour soins buccaux |
GB201721001D0 (en) * | 2017-12-15 | 2018-01-31 | Glaxosmithkline Consumer Healthcare (Uk) Ip Ltd | Novel Composition |
US11752072B2 (en) | 2019-03-11 | 2023-09-12 | University Of Utah Research Foundation | Quick set cements for dental pulp capping and related methods of use |
KR102293306B1 (ko) * | 2019-11-26 | 2021-08-25 | 단국대학교 천안캠퍼스 산학협력단 | 이온방출형 생활성 글라스 나노파티클을 포함하는 항염증용 약학적 조성물 |
GB202214700D0 (en) | 2022-10-06 | 2022-11-23 | GlaxoSmithKline Consumer Healthcare UK IP Ltd | Dentifrice composition |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3981736A (en) * | 1973-05-23 | 1976-09-21 | Ernst Leitz G.M.B.H. | Biocompatible glass ceramic material |
DE2501683C3 (de) * | 1975-01-17 | 1979-11-29 | Ernst Leitz Wetzlar Gmbh, 6300 Wetzlar | Polymeres Verbundmaterial für prothetische Zwecke und Verfahren zu seiner Herstellung |
DE69012260T2 (de) * | 1989-08-29 | 1995-01-12 | Univ Kyoto | Bioaktiver Zement. |
DE3934803A1 (de) * | 1989-10-19 | 1991-04-25 | Voco Chemie Gmbh | Verfahren zur herstellung eines dentalen zementes |
WO1991017777A2 (fr) * | 1990-05-22 | 1991-11-28 | University Of Florida | Compositions de verre bioactives injectables et procede de reconstitution de tissus |
EP0511868B1 (fr) * | 1991-05-01 | 1996-09-25 | Chichibu Onoda Cement Corporation | Compositions durcissables pour usage médical ou dentaire |
GB9115154D0 (en) * | 1991-07-12 | 1991-08-28 | Patel Bipin C M | Sol-gel composition for producing glassy coatings |
GB9115153D0 (en) * | 1991-07-12 | 1991-08-28 | Patel Bipin C M | Sol-gel composition for producing glassy coatings |
IT1259090B (it) * | 1992-04-17 | 1996-03-11 | Fidia Spa | Biomaterialli per protesi d'osso |
JP4180657B2 (ja) * | 1996-01-29 | 2008-11-12 | ユニバーシティ オブ メリーランド、バルティモア | 生理活性ガラス組成物 |
US5735942A (en) * | 1996-02-07 | 1998-04-07 | Usbiomaterials Corporation | Compositions containing bioactive glass and their use in treating tooth hypersensitivity |
-
1994
- 1994-10-06 FI FI944672A patent/FI104881B/fi not_active IP Right Cessation
-
1995
- 1995-10-02 RU RU97108274/14A patent/RU2152778C1/ru active
- 1995-10-02 KR KR1019970702117A patent/KR100381308B1/ko not_active IP Right Cessation
- 1995-10-02 CA CA002200218A patent/CA2200218C/fr not_active Expired - Lifetime
- 1995-10-02 US US08/809,867 patent/US5891233A/en not_active Expired - Lifetime
- 1995-10-02 DE DE69530608T patent/DE69530608T2/de not_active Expired - Lifetime
- 1995-10-02 AT AT95934137T patent/ATE238753T1/de active
- 1995-10-02 AU AU36537/95A patent/AU702580B2/en not_active Expired
- 1995-10-02 EP EP95934137A patent/EP0804136B1/fr not_active Expired - Lifetime
- 1995-10-02 PL PL95319483A patent/PL319483A1/xx unknown
- 1995-10-02 WO PCT/FI1995/000539 patent/WO1996010985A1/fr active IP Right Grant
- 1995-10-02 ES ES95934137T patent/ES2198444T3/es not_active Expired - Lifetime
- 1995-10-02 JP JP51235096A patent/JP3524102B2/ja not_active Expired - Lifetime
- 1995-10-02 CZ CZ1997850A patent/CZ292434B6/cs not_active IP Right Cessation
- 1995-10-02 HU HU9702277A patent/HU222368B1/hu active IP Right Grant
-
1997
- 1997-04-04 NO NO19971563A patent/NO310094B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2200218C (fr) | 2003-07-22 |
CZ292434B6 (cs) | 2003-09-17 |
HUT77863A (hu) | 1998-08-28 |
ES2198444T3 (es) | 2004-02-01 |
CA2200218A1 (fr) | 1996-04-18 |
HU222368B1 (hu) | 2003-06-28 |
JPH10506908A (ja) | 1998-07-07 |
PL319483A1 (en) | 1997-08-04 |
JP3524102B2 (ja) | 2004-05-10 |
DE69530608T2 (de) | 2004-02-26 |
KR100381308B1 (ko) | 2003-09-26 |
AU3653795A (en) | 1996-05-02 |
US5891233A (en) | 1999-04-06 |
AU702580B2 (en) | 1999-02-25 |
CZ85097A3 (en) | 1997-09-17 |
ATE238753T1 (de) | 2003-05-15 |
NO971563D0 (no) | 1997-04-04 |
EP0804136B1 (fr) | 2003-05-02 |
WO1996010985A1 (fr) | 1996-04-18 |
EP0804136A1 (fr) | 1997-11-05 |
FI944672A (fi) | 1996-04-07 |
RU2152778C1 (ru) | 2000-07-20 |
FI944672A0 (fi) | 1994-10-06 |
KR970705969A (ko) | 1997-11-03 |
NO971563L (no) | 1997-04-04 |
DE69530608D1 (de) | 2003-06-05 |
FI104881B (fi) | 2000-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO310094B1 (no) | Anvendelse av bioaktivt silikaglass og sammensetninger som inneholder bioaktivt silikaglass | |
US6244871B1 (en) | Bioactive glass compositions and methods of treatment using bioactive glass | |
Utneja et al. | Current perspectives of bio-ceramic technology in endodontics: calcium enriched mixture cement-review of its composition, properties and applications | |
Casey et al. | A review of the submerged-root concept | |
WO1997027148A1 (fr) | Composition de verre bioactif et methodes de traitement utilisant ce verre bioactif | |
WO1997027148A9 (fr) | Composition de verre bioactif et methodes de traitement utilisant ce verre bioactif | |
Leite et al. | Influence of root-surface conditioning with acid and chelating agents on clot stabilization. | |
JP4458373B2 (ja) | 耐酸性被膜形成用歯科用水溶液およびその製造方法 | |
US10821058B2 (en) | Conditioning composition | |
US9925397B2 (en) | Conditioning composition | |
Febriani et al. | The Potential of Hydroxyapatite Toothpaste towards the Hypersensitive Tooth | |
ElnazShafiq et al. | Investigating the Effect of 45S5 Bioactive Glasses and Calcium Oxalate (Gluma) Covering the Dentinal Tubules in Dental Sensitivity | |
Elhalabi et al. | Biological effect of a novel alcoholic and aqueous plant extracts of moringa as a bioactive irrigant on radicular dentin ultra-structural surface morphology | |
Ubolsa-Ard et al. | Influence of surface pre-reacted glass-ionomer (S-PRG) filler eluate on collagen morphology, remineralization, and ultimate tensile strength of demineralized dentin | |
A Elbegawy et al. | Effect of Different Biomimetic Materials on White Spot Lesions in Enamel (A split-mouth clinical trial) | |
Hülsmann et al. | Delayed endodontic and prosthetic treatment of two traumatized incisors | |
TWI482636B (zh) | 抗敏感牙膏 | |
Melia | Management Of A Radicular Cyst With Synthetic Bone Graft Subtitute (Case Report) | |
Melia | MANAGEMENT OF A RADICULAR CYST WITH SYNTHETIC BONE GRAFT SUBTITUTE | |
Elbegawy et al. | AL-AZHAR | |
Sonali et al. | International Journal of Scientific Research and Reviews | |
MXPA98006105A (en) | Bioactive glass compositions and treatment methods that use bioact glass |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |